Universal Corporation is a global leaf tobacco supplier and agriproducts company with operations in more than 30 countries, and its fiscal year runs from April through March. The second quarter of fiscal 2027, which ended September 30, 2026, serves as an important checkpoint because the business is highly seasonal. Green tobacco buying, customer commitments, and shipping schedules from regions such as Africa and Brazil heavily influence quarterly results. The company entered the quarter navigating a delayed oversupply cycle in tobacco, which had already weighed on its fiscal first quarter, when revenue and EPS missed expectations. For investors, this report offers a read on whether shipment timing is normalizing and whether the company's Ingredients segment can begin recovering from fixed-cost and demand headwinds. I also checked comparable setups in the sector using Tickeron’s AI Screener to see how UVV stacks up against peers.
Universal Corporation reported second quarter fiscal 2027 revenue of $621.8 million, an 18% decline from $754.2 million in the same period last year and below the roughly $630.1 million analysts had anticipated. Diluted EPS was $0.50, down 63% from $1.36 a year earlier and below the consensus estimate of $0.58. On an adjusted, non-GAAP basis (a measure that excludes certain one-time items), diluted EPS was $0.39.
Net income attributable to Universal Corporation fell to approximately $12.6 million, while adjusted operating income declined 41% to about $39.9 million. Gross profit margin narrowed to 17.3% from 18.5%. For the first half of fiscal 2027, consolidated revenue fell 15% to about $1.1 billion, driven by an 18% decline in tobacco sales volumes, and the Ingredients segment posted an operating loss of $2.7 million versus income of $1.5 million a year earlier. From what I see, the volume shortfall is the main driver here rather than any sudden shift in underlying demand.
Because Universal Corporation released its results after the market close on November 4, 2026, the full market reaction is still developing as investors digest the figures in subsequent sessions. The quarter's top- and bottom-line misses, combined with a sharp year-over-year EPS decline, reinforce the narrative that fiscal 2027 is unfolding as a timing-driven year. Management emphasized that the shortfall reflects the slower shipment cadence of a delayed oversupply cycle rather than a fundamental change in demand, and that customer commitments remain in line with full-year sales plans. Investor sentiment heading forward will likely hinge on whether second-half shipment volumes recover as projected and whether the Ingredients segment's restructuring efforts begin to show measurable progress.
Universal Corporation enters the back half of fiscal 2027 with management pointing to a second-half-weighted shipment schedule. The company said customer commitments align with its full-year sales plans, and uncommitted tobacco inventories stood at 19%, within its target range. If shipping instructions from Africa and Brazil continue to normalize, the Tobacco Operations segment could recover some of the ground lost in the first half.
Investors should watch tobacco shipment volumes and the pace of green tobacco buying, since these drive the company's highly seasonal revenue. The broader oversupply environment in flue-cured, burley, and dark air-cured tobacco remains a key variable, as it can pressure both volumes and pricing.
On the Ingredients side, management is restructuring the platform into a more integrated organization, a process it expects to continue through the next fiscal year. Progress here matters because the segment has faced weak consumer-packaged-goods demand, tight Pacific Northwest apple supplies, raw material constraints, and inflationary cost pressures.
Finally, balance sheet discipline will stay in focus. With total debt near $1.20 billion and roughly $945 million of available liquidity, the company's ability to fund seasonal working capital while managing leverage will be closely watched as shipments accelerate later in the fiscal year. I’m watching this closely because any sustained improvement in volumes could shift the tone for the rest of the year.
I often turn to Tickeron’s AI Screener when reviewing quarterly results like these. It lets me quickly filter for stocks with similar seasonal patterns or margin profiles, which helps put UVV’s numbers in better context without spending hours on manual comparisons. The tool’s ability to combine technical signals with fundamentals has become a regular part of my process for names in the tobacco and agriproducts space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UVV advanced for three days, in 176 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UVV's RSI Indicator exited the oversold zone, 8 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 32%.
The Moving Average Convergence Divergence (MACD) for UVV just turned positive on October 28, 2026. Looking at past instances where UVV's MACD turned positive, the stock continued to rise in 24 of 46 cases over the following month. The odds of a continued upward trend are 52%.
UVV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 60 cases where UVV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UVV as a result. In 46 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UVV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
The Aroon Indicator for UVV entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. UVV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.708) is normal, around the industry mean (-7.557). UVV has a moderately high P/E Ratio (51.934) as compared to the industry average of (12.929). UVV's Projected Growth (PEG Ratio) (11.534) is slightly higher than the industry average of (3.595). Dividend Yield (0.084) settles around the average of (0.059) among similar stocks. UVV's P/S Ratio (0.393) is slightly lower than the industry average of (2.780).
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UVV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company that processes and distributes burley leaf tobaccos
Industry Tobacco